3D printing gets really BIG + Jerry Yang on FinTech

Top investment opportunities
Startup of the Week: Plantish has a 'sea' of opportunities
AEYE Health: Strong signs for eye disease detection
Size matters: 3D printing that's larger than life
Jerry Yang: 'I do not invest in public markets'
Scopio Labs raises $50M for its AI-powered, digital blood tests
Freightos boosts Qatar Airways Cargo online bookings
UAE's Mashreq Bank taps ThetaRay for financial fraud prevention
TytoCare receives European CE mark for remote lung analyzer
CytoReason and Pfizer extend drug development collaboration
Orbital Insight wins DOD contract to detect satellite disruption
BeeFree Agro turns drones into cowboys
Introductions
More than 4,500 high-tech jobs

Startup of the Week:
Forbes: A 'sea' of opportunities for alternative fish

Plantish aims to produce 3D-printed fish from soy, seaweed and other vegetable proteins, but unlike other offerings of fish flakes or chunks, "the company is working on an innovative technology that enables the creation of whole cut fish fillets," Forbes reports. The aim is to 3D print plant-based whole-cut "salmon" at cost parity with live salmon, and with the same taste, color, consistency and composition. The company has a prototype facility in operation producing "salmon" steaks that are recommended and used by leading Israeli chef Nir Zook. CEO Ofek Ron heads a strong team with deep experience in 3D printing and the plant-based food industry. OurCrowd is joining a pre-revenue up to $12M round led by State of Mind Ventures.

AEYE Health: Strong signs for eye disease detection

A clinical trial using software from our currently-funding company AEYE Health showed positive results in diagnosing a debilitating eye disease, Opthalmology Today reports. Single images of eyes were run through AEYE's AI-powered platform, which detected signs of more-than-mild diabetic retinopathy that can lead to blindness. The company is seeking FDA clearance for its autonomous screening solution for the disease. AEYE Health is funding now on the OurCrowd platform. Click for details.

Size matters: 3D printing gets larger than life

Largix has created the world's largest robotic 3D printing platform, able to produce industrial-sized objects from common plastic materials for the first time. "This will be a gamechanger for us," says Geert Denutte, the founder of CGK, a Belgian company that makes 13-foot-high storage tanks for storing and transporting hazardous liquids. "Nobody else is doing such technology. We estimate it will save us up to 50 percent in costs," he tells Linda Gradstein in The Times of Israel. In addition, because the technology is automated, it can work "25 hours a day," says Denutte, dramatically cutting the time required to make the tanks. Largix is set to transform 3D printing for the storage and chemicals industry and also has its sights set on the huge construction sector. The company is now funding on the OurCrowd platform.

Jerry Yang: 'I do not invest in public markets'

"I do not invest in public markets," Yahoo! founder Jerry Yang revealed in an online discussion with OurCrowd on Investing in the Future of FinTech. The general partner of AME Cloud Ventures is now focused on cloud and FinTech investing. "If you take a long-term perspective, then growing companies that are demonstrating growth and actually showing some strong fundamentals are going to do just fine over time. Whether 2022 will be an up year or down year, it shouldn't matter - although I'm sure it does to some people." Yang discussed the impact of companies like Alibaba and Tencent and the "leapfrog opportunities" now available for FinTech startups in various markets around the world. If you missed the live event, click below to stream the catchup featuring Yang and Claire Tomkins, the CEO of Future Family; Guy Kashtan, CEO of Rewire; Daniel Tsiddon of Viola FinTech; and Michal Geva, Managing Partner & Co-Founder, Triventures.

Take a Look at Funding Opportunities

Binah_logo2021_black_tagline

Helps airlines improve profitability by reducing aircraft turnaround times, identifying potential delays, improving safety and recognizing hazards.

Learn more

Binah.ai enables vastly improved telehealth care with vital sign monitoring that needs no equipment other than a smartphone.

Learn more

Autonomous, machine learning big data analysis platform that finds and fixes revenue-linked incidents in real time, improving business performance.

Learn more

See all opportunities here

Top Investment Opportunities

Sequentify: DNA sequencing as fast and affordable as a blood test

Sequentify aims to make next-generation DNA sequencing as fast and affordable as a blood test, slashing the time and cost to create the genetic information required for the fast-growing application of personalized medicine. Emerging from stealth with initial tests for pregnancy screening and oncology panels, the company forecasts 600% revenue increase in 2022 and a further 160% growth in 2023. CEO Ophir Herbst founded and led Cisco spin-off Jungo Connectivity to its IPO. His strong team are alumni of Jungo, Cisco and the Weizmann Institute. This fast-growing sector includes Grail acquired for $8B, ArcherDX acquired for $1.4B, SOPHiA Genetics' $234M IPO and Immunai's $215M Series C.

Superpedestrian: Racing to 10X revenue growth in 2021

MIT spin-out Superpedestrian has proven its ability to design, manufacture, manage and operate fleets of e-scooters in multiple cities. Its LINK scooters raced to 10X YOY revenue growth in 2021 to $20M and the company forecasts 4X growth in 2022, reaching profitability in 2023. Since LINK was launched in 9 markets in 2020 its market penetration has expanded rapidly to 60 locations in 2021, projecting more than 70 in 2022. An M&A agreement enabled the company to acquire 4 markets from WIND, gaining its first foothold in the lucrative UK and France locations, which were closed until now. Superpedestrian's superior, safer Vehicle Intelligence operating system enables it to achieve industry-leading unit economics with a 30% margin to reach profitability even in smaller markets. It also enhances safety by identifying dangerous rider behavior, automatically applying brakes to slow or stop the vehicle, also protecting pedestrians. A new high-margin advanced software product line will be launched in 2022. Superpedestrian has plans to expand into a new vertical, licensing the software as a SaaS offering to OEMs for use in light electric vehicles. Funds from this $50M Series C round will be used to expand LINK e-scooter's reach and develop its software licensing activities.

Cellium to present 5G indoor wireless at MWC in Barcelona

Augmented reality, virtual reality, robotic surgery, and the internet of things all require the ubiquitous, reliable, uninterrupted, wireless connectivity of 5G wireless internet. But 5G's higher mid-band frequencies have trouble penetrating walls and windows. Current indoor 5G systems are expensive and suited only to large venues, leaving most small and medium businesses behind. Cellium's Insphere makes the 5G difference, enabling next-generation wireless connectivity even indoors - at 25% of the cost of competing systems. Cellium will be exhibiting at MWC in Barcelona. The company is currently in MOU discussions with system vendors, a major semiconductor company and leading wireless network operators in the US, Japan, Russia and elsewhere. Cellium's impressive team is led by CEO Dror Jerushalmi, co-founder and CEO of Valens (NYSE:VLN), a leading fabless semiconductor company whose HDBaseT technology has been adopted as a standard for connectivity in the audio-video and automotive markets. COO Roy Kinamon was formerly the head of the Israel Design Center for STMicroelectronics (NASDAQ: STM). CFO Gil Bahat previously served as the CFO for Zeekit, acquired by Walmart. Join OurCrowd as we lead this $12M round with Mivtach Shamir. Co-investors include GBZ Technologies.

Top Tech News

Scopio Labs raises $50M for its AI-powered, digital blood tests

Medtech startup Scopio Labs completed a $50M round to expand its FDA-approved imaging and AI analysis systems which significantly enhances diagnostic capabilities, Globes reports. "In the 21^st century, people shouldn't be looking through microscopes, manually counting cells," says Itai Hayut, Scopio's CEO. "Scopio's full-field imaging and AI platform means tens of thousands of cells in a single sample can be examined, counted and analyzed instantly and reviewed by a specialist regardless of location." OurCrowd investors can still join this round. Click HERE for details.

Freightos boosts Qatar Airways Cargo online bookings

Qatar Airways Cargo, the world's largest cargo airline, is getting a huge boost in online bookings thanks to our portfolio company Freightos. Since the airline started using the company's WebCargo platform in February 2021, they've received an additional 50,000 orders, The Peninsula reports.

UAE's Mashreq Bank taps ThetaRay for financial fraud prevention

Mashreq Bank in the UAE will be using software from our portfolio company ThetaRay to help prevent money laundering, Reuters reports. The platform identifies financial cyberthreats so users can take action against suspicious transactions. "ThetaRay's technology, underpinned by advanced machine-learning-based models complementing rules, sets the foundation for next-generation transaction monitoring," says Scott Ramsay, Group Head of Compliance at Mashreq Bank.

TytoCare receives European CE mark for remote lung analyzer

Qure portfolio company TytoCare has received CE mark approval for its Lung Sounds Analyzer used in remote medical exams, paving the way for its immediate launch in Europe, Massive Device reports. Tyto Lung is a web-based software module that analyzes recordings made of the respiratory system by the TytoCare kit. The company is also seeking FDA clearance for the device.

CytoReason and Pfizer extend drug development collaboration

Our portfolio company CytoReason will continue to provide its computational disease models to help Pfizer develop new drugs as the two companies extend their collaboration which began in 2019, the Jerusalem Post reports. CytoReason's platform has provided Pfizer with multiple insights in several R&D programs for over 20 diseases so far.

Orbital Insight wins DOD contract to detect satellite disruption

Orbital Insight will provide its geospatial intelligence knowhow to the US Department of Defense after it won a contract to create a new platform to identify satellite spoofing. The system will use AI and commercially available data to detect falsified or manipulated satellite signals which can be a risk to both government and commercial operations.

BeeFree Agro turns drones into cowboys

Living in the periphery might be a disadvantage for some startups, but for BeeFree Agro, it's a necessity, Calcalist reports. The company, part of OurCrowd's Labs/02 incubator, uses drones to help farmers manage and move livestock. "We need to be up here in the north - our test sites, our cattle farms are in the Galilee and Golan Heights, it is crucial for us to be next to the farmers, next to the fields, so we can run our tests and be close to our customers," says CEO Noam Azran.

THE FOREGOING DETAILS ARE BASED ON INFORMATION RECEIVED FROM, AND VERIFIED SOLELY BY, THE RESPECTIVE PORTFOLIO COMPANIES. CERTAIN INFORMATION IN THIS COMMUNICATION CONTAINS "FORWARD-LOOKING INFORMATION" UNDER APPLICABLE SECURITIES LAWS ("FORWARD-LOOKING STATEMENTS"). THESE MAY INCLUDE, AMONG OTHERS, PROJECTED PERFORMANCE; EXPECTED DEVELOPMENT OF THE COMPANIES' BUSINESS, PROJECTS AND PARTNERSHIPS; EXECUTION OF THE COMPANIES' VISION AND GROWTH STRATEGY; AND THE LIKE. FORWARD-LOOKING STATEMENTS ARE NOT GUARANTEES OF FUTURE PERFORMANCE AND SHOULD NOT BE RELIED ON IN ANY WAY.

Nothing contained in and accompanying this communication shall be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security by OurCrowd, its portfolio companies or any third party. Information regarding OurCrowd's limited partnerships and/or portfolio companies and the investment opportunities on OurCrowd's website is intended and available for accredited investors only (criteria at OurCrowd). OurCrowd urges potential investors to consult with licensed legal professionals and investment advisors for any legal, tax, insurance, or investment advice. OurCrowd operates in Canada through OurCrowd Canada Inc., an exempt market dealer registered in the Provinces of British Columbia, Alberta, Manitoba, Ontario, Quebec and Nova Scotia.